Bladder cancer biomarker array to detect aberrant levels of proteins in urine
- 7 November 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 140 (3) , 724-735
Abstract
Bladder cancer (BCa) is a serious malignancy of the urinary tract worldwide and also prominent for its high rate of recurrence incorporating 50% of all treated patients.Keywords
This publication has 39 references indexed in Scilit:
- Standardization of Diagnostic Biomarker Concentrations in Urine: The Hematuria CaveatPLOS ONE, 2012
- A Multi-Analyte Assay for the Non-Invasive Detection of Bladder CancerPLOS ONE, 2012
- IL-8 as a urinary biomarker for the detection of bladder cancerBMC Urology, 2012
- Vascular Endothelial Growth Factor, Carbonic Anhydrase 9, and Angiogenin as Urinary Biomarkers for Bladder Cancer DetectionUrology, 2012
- Profilin 1 is a Potential Biomarker for Bladder Cancer AggressivenessMolecular & Cellular Proteomics, 2012
- Miniaturized Protein Microarray with Internal Calibration as Point-of-Care Device for Diagnosis of Neonatal SepsisSensors, 2012
- Protein chip for the parallel quantification of high and low abundant biomarkers for sepsisAnalytical Biochemistry, 2011
- Stress Proteins and Cytokines are Urinary Biomarkers for Diagnosis and Staging of Bladder CancerEuropean Urology, 2011
- Economic aspects of bladder cancer: what are the benefits and costs?World Journal of Urology, 2009
- Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase SpeciesClinical Cancer Research, 2008